Cargando…

Multicenter Retrospective Analysis of the Effectiveness and Safety of Rituximab in Korean Patients with Refractory Systemic Lupus Erythematosus

Objective. Although two recent randomized placebo-controlled trials of rituximab (RTX) failed to demonstrate efficacy in systemic lupus erythematosus (SLE), clinicians continue to use off-label RTX for cases refractory to current treatments. We evaluated the effectiveness and safety of rituximab for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bang, So-Young, Lee, Chang Keun, Kang, Young Mo, Kim, Hyoun-Ah, Suh, Chang-Hee, Chung, Won Tae, Park, Yong-Beom, Choe, Jung-Yoon, Kim, Tae-Jong, Park, Yong-Wook, Yoo, Dae-Hyun, Bae, Sang-Cheol, Lee, Hye-Soon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523406/ https://www.ncbi.nlm.nih.gov/pubmed/23304457 http://dx.doi.org/10.1155/2012/565039

Ejemplares similares

Impact of Childbearing Decisions on Family Size of Korean Women with Systemic Lupus Erythematosus
por: Kim, In Je, et al.
Publicado: (2016)

Liver X receptors alpha gene (NR1H3) promoter polymorphisms are associated with systemic lupus erythematosus in Koreans
por: Jeon, Ja-Young, et al.
Publicado: (2014)

Efficacy and Safety of Rituximab in Korean Patients with Refractory Inflammatory Myopathies
por: Ahn, Ga Young, et al.
Publicado: (2020)

Prevalence of Human Papilloma Virus Infections and Cervical Cytological Abnormalities among Korean Women with Systemic Lupus Erythematosus
por: Lee, You-Hyun, et al.
Publicado: (2010)

Associated clinical factors for serious infections in patients with systemic lupus erythematosus
por: Jung, Ju-Yang, et al.
Publicado: (2019)

Rituximab can Decrease Proteinuria in Refractory Lupus Nephritis
por: Suh, Chang-Hee
Publicado: (2022)

Rituximab for Remission Induction and Maintenance in Refractory Systemic Lupus Erythematosus
por: Bonilla-Abadía, Fabio, et al.
Publicado: (2014)

Rituximab in the treatment of extensive and refractory subacute cutaneous lupus erythematosus
por: Penha, Mariana Álvares, et al.
Publicado: (2018)

S100A8 in Serum, Urine, and Saliva as a Potential Biomarker for Systemic Lupus Erythematosus
por: Kim, Ji-Won, et al.
Publicado: (2022)

Imputing Variants in HLA-DR Beta Genes Reveals That HLA-DRB1 Is Solely Associated with Rheumatoid Arthritis and Systemic Lupus Erythematosus
por: Kim, Kwangwoo, et al.
Publicado: (2016)

Sex hormones affect the pathogenesis and clinical characteristics of systemic lupus erythematosus
por: Kim, Ji-Won, et al.
Publicado: (2022)

Increased Immunoglobulin Gamma-3 Chain C in the Serum, Saliva, and Urine of Patients with Systemic Lupus Erythematosus
por: Jung, Ju-Yang, et al.
Publicado: (2023)

Rituximab Therapy for Refractory Autoimmune Thrombocytopenia in Patients with Systemic Lupus Erythematosus
por: Atay, Didem, et al.
Publicado: (2012)

Refractory Orbital Myositis in Systemic Lupus Erythematosus A Role for Rituximab
por: Rodrigues Morais, Joana, et al.
Publicado: (2021)

Salivary Immunoglobulin Gamma-3 Chain C Is a Promising Noninvasive Biomarker for Systemic Lupus Erythematosus
por: Jung, Ju-Yang, et al.
Publicado: (2021)

Three Clinical Clusters Identified through Hierarchical Cluster Analysis Using Initial Laboratory Findings in Korean Patients with Systemic Lupus Erythematosus
por: Jung, Ju-Yang, et al.
Publicado: (2022)

Two Cases of Refractory Thrombocytopenia in Systemic Lupus Erythematosus that Responded to Intravenous Low-Dose Cyclophosphamide
por: Park, Hee-Jin, et al.
Publicado: (2013)

Prevalence of osteoporosis in patients with systemic lupus erythematosus: A multicenter comparative study of the World Health Organization and fracture risk assessment tool criteria
por: Jung, Ju-Yang, et al.
Publicado: (2020)

Polymorphisms of MFGE8 are associated with susceptibility and clinical manifestations through gene expression modulation in Koreans with systemic lupus erythematosus
por: Baek, Wook-Young, et al.
Publicado: (2019)

Thrombocytopenia in Systemic Lupus Erythematosus: Clinical Manifestations, Treatment, and Prognosis in 230 Patients
por: Jung, Jin-Hee, et al.
Publicado: (2016)

Elevated Salivary Alpha-Amylase Level, Association Between Depression and Disease Activity, and Stress as a Predictor of Disease Flare in Systemic Lupus Erythematosus: A Prospective Case–Control Study
por: Jung, Ju-Yang, et al.
Publicado: (2015)

Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy
por: Tanaka, Yoshiya, et al.
Publicado: (2016)

Tuberculosis presenting as isolated bronchonodal fistula in a patient with systemic lupus erythematosus: Case report
por: Bae, Kyungsoo, et al.
Publicado: (2017)

Hyponatremia in patients with systemic lupus erythematosus
por: Il Shin, Jae, et al.
Publicado: (2016)

Successful treatment of thrombotic thrombocytopenic purpura with plasmapheresis and anti-CD20 antibodies in a patient with immune thrombocytopenia and systemic lupus erythematosus: Case report
por: Jung, Ju-Yang, et al.
Publicado: (2022)

Myopericarditis in a Korean Young Male With Systemic Lupus Erythematosus
por: Park, Kyu Tae, et al.
Publicado: (2011)

Clinical and Genetic Risk Factors Associated With the Presence of Lupus Nephritis
por: Shin, Jung-Min, et al.
Publicado: (2021)

Subretinal fluid in a patient with systemic lupus erythematosus
por: Park, Jong Beom, et al.
Publicado: (2022)

Systemic Lupus Erythematosus Presenting Earlier as Retinal Vaso-Occlusion
por: Song, Yong-Ho, et al.
Publicado: (2001)

Systemic Lupus Erythematosus Associated with Familial Moyamoya Disease
por: Lee, Chang Min, et al.
Publicado: (2003)

Degos-Like Lesions Associated with Systemic Lupus Erythematosus
por: Jang, Min Soo, et al.
Publicado: (2017)

Initial Preserved Renal Function as a Predictor of Favorable Renal Response to Rituximab in Refractory or Relapsing Lupus Nephritis: A Single-center Cohort Study in Korea
por: Choi, Su Jin, et al.
Publicado: (2022)

Very Severe and Refractory Noninfectious Cystitis in Patients with Systemic Lupus Erythematosus: Potential Role of Rituximab Therapy
por: Ocampo-Piraquive, Vanessa, et al.
Publicado: (2021)

Refractory Bullous Systemic Lupus Erythematosus Successfully Treated with Rituximab: A Case Report and Literature Review
por: Ratanapokasatit, Yanisa, et al.
Publicado: (2023)

Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies
por: Petricca, Luca, et al.
Publicado: (2020)

Causes, Risk Factors, and Clinical Outcomes of Stroke in Korean Young Adults: Systemic Lupus Erythematosus is Associated with Unfavorable Outcomes
por: Kwon, Hyuk Sung, et al.
Publicado: (2020)

Efficacy and safety of rituximab biosimilar in refractory lupus
por: Pongtarakulpanit, Nantakarn, et al.
Publicado: (2020)

Rituximab therapy for juvenile-onset systemic lupus erythematosus
por: Nwobi, Obioma, et al.
Publicado: (2007)

Rituximab reduces the hospitalization in patients with systemic lupus erythematosus
por: Martínez-Pérez, R, et al.
Publicado: (2010)

A Case of Systemic Lupus Erythematosus Presenting as Malignant Hypertension with Hypertensive Retinopathy
por: Choe, Jung-Yoon, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_asg03v9430hdqa3s1079vuhc2a